Evidence map›Paper›PMID 31269062›Full record

ArticlePloS one2019

Dissociation of natriuresis and diuresis by oxytocin molecular forms in rats.

Marek Jankowski, Bogdan A Danalache, Eric Plante, Ahmed Menaouar, Maria Florian, Ju Jing Tan, Ryszard Grygorczyk, Tom L Broderick, Jolanta Gutkowska

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Partial nephrogenic diabetes insipidus with a novel arginine vasopressin receptor 2 gene variant.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2022
    Article
  3. Article
  4. Nephrogenic diabetes insipidus caused by a novel missense variant (p.S127Y) in theClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Marek JankowskiDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.ORCID 0000-0002-1245-0733
Bogdan A DanalacheDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.
Eric PlanteDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.
Ahmed MenaouarDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.
Maria FlorianDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.ORCID 0000-0002-1211-3614
Ju Jing TanDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.
Ryszard GrygorczykDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.
Tom L BroderickDepartment of Physiology, College of Graduate Studies, Midwestern University, Glendale, AZ, United States of America.
Jolanta GutkowskaDepartment of Medicine, University of Montreal, CRCHUM, Quebec, Canada.
Université de Montréal · CAMidwestern University · US

Funding

CIHR
6 · The paper itself

Abstract

In the rat, oxytocin (OT) produces dose-dependent diuretic and natriuretic responses. Post-translational enzymatic conversion of the OT biosynthetic precursor forms both mature and C-terminally extended peptides. The plasma concentrations of these C-terminally extended peptides (OT-G; OT-GK and OT-GKR) are elevated in newborns and pregnant rats. Intravenous injection of OT-GKR to rats inhibits diuresis, whereas injection of amidated OT stimulates diuresis. Since OT and OT-GKR show different effects on the urine flow, we investigated whether OT-GKR modulates renal action by inhibition of the arginine-vasopressin (AVP) receptor V2 (V2R), the receptor involved in renal water reabsorption. Experiments were carried out in the 8-week-old Wistar rats receiving intravenous (iv) injections of vehicle, OT, OT-GKR or OT+OT-GKR combination. OT (10 μmol/kg) increased urine outflow by 40% (P<0.01) and sodium excretion by 47% (P<0.01). Treatment with OT-GKR (10 μmol/kg) decreased diuresis by 50% (P<0.001), decreased sodium excretion by 50% (P<0.05) and lowered potassium by 42% (P<0.05). OT antagonist (OTA) reduced diuresis and natriuresis exerted by OT, whereas the anti-diuretic effect of OT-GKR was unaffected by OTA. The treatment with V2R antagonist (V2A) in the presence and absence of OT induced diuresis, sodium and potassium outflow. V2A in the presence of OT-GKR only partially increased diuresis and natriuresis. Autoradiography and molecular docking analysis showed potent binding of OT-GKR to V2R. Finally, the release of cAMP from CHO cells overexpressing V2 receptor was induced by low concentration of AVP (EC50:4.2e-011), at higher concentrations of OT (EC50:3.2e-010) and by the highest concentrations of OT-GKR (EC50:1.1e-006). OT-GKR potentiated cAMP release when combined with AVP, but blocked cAMP release when combined with OT. These results suggest that OT-GKR by competing for the OT renal receptor (OTR) and binding to V2R in the kidney, induces anti-diuretic, anti-natriuretic, and anti-kaliuretic effects.

Indexed as

DiuresisNatriuresisAnimalsAutoradiographyBinding, CompetitiveCell LineCHO CellsCricetinaeCricetulusCyclic AMPElectrolytesHumansKidneyMolecular Docking SimulationOxytocinPeptidesCyclic AMPElectrolytesOxytocinPeptidesReceptors, VasopressinVasopressins

Identifiers

PMID31269062
PMCPMC6608960
OpenAlexW2953460955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.